Statements (20)
Predicate | Object |
---|---|
gptkbp:instanceOf |
gptkb:biotechnology
|
gptkbp:acquiredBy |
gptkb:Flexion_Therapeutics
|
gptkbp:acquisitionYear |
2021
|
gptkbp:CEO |
David Stack
|
gptkbp:focusesOn |
non-opioid pain management
|
gptkbp:formerName |
Pacira Biosciences
|
gptkbp:founded |
2007
|
gptkbp:headquartersLocation |
gptkb:Parsippany,_New_Jersey,_United_States
|
https://www.w3.org/2000/01/rdf-schema#label |
Pacira Pharmaceuticals
|
gptkbp:industry |
pharmaceuticals
|
gptkbp:notableProduct |
Exparel
|
gptkbp:numberOfEmployees |
over 700
|
gptkbp:publiclyTraded |
true
|
gptkbp:stockSymbol |
PCRX
|
gptkbp:tradedOn |
gptkb:NASDAQ
|
gptkbp:website |
https://www.pacira.com/
|
gptkbp:bfsParent |
gptkb:Aisling_Capital
gptkb:Depocyt gptkb:Pacira_BioSciences |
gptkbp:bfsLayer |
8
|